V6W-27530-25901 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-12
Dose 1 — Pfizer-BioNTech
2021-03-14
Registered in v-safe
2021-03-14
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-03-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-19
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-04
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-09-13
Survey response — 6 months, dose 1
MedDRA: Cholestasis, HELLP syndrome — Feeling: Good · Get care from a doctor or other healthcare professional · Hospitalization

Free text: HELLP syndrome and cholestasis

MedDRA releases: 2024-11 · check-in free text available
2021-09-13
Report sent to call center — 6 months, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-09-15
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-12	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-09-13	Unsuccessful

Free text

Release 9 — 6 months, dose 1

2021-09-13

Symptoms: HELLP syndrome and cholestasis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cholestasis	·	·	✓
SD	HELLP syndrome	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release